|Articles|January 18, 2021

Supplements and Featured Publications

  • COPD Stakeholder Summit: Utilizing Peak Inspiratory Flow Rates to Individualize Treatment and Improve Outcomes

Chronic Obstructive Pulmonary Disease Stakeholder Summit: Utilizing Peak Inspiratory Flow Rates to Individualize Treatment and Improve Outcomes

This activity is supported by an educational grant from Boehringer Ingelheim.

This AJMC® Stakeholder Summit provides a multistakeholder perspective on current treatment options, recent guideline recommendations, and approaches for health care decision makers and clinicians for the individualized management of chronic obstructive pulmonary disease (COPD).


Related to this article

Robert Z. Orlowski, MD, PhD | Image: MD Anderson Cancer Center
At a Stakeholder Interchange convened by The American Journal of Managed Care® in Houston, Texas, oncologists and pharmacists from academic and community practices debated how teclistamab- and talquetamab-based regimens stack up against CAR T-cell therapy in second-line multiple myeloma, and what it will take—staffing, caregiver support, hospital partnerships, and payer buy-in—to move step-up dosing out of the hospital and into the clinic.